Standout Papers

Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, si... 2016 2026 2019 2022 900
  1. Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial (2016)
    Howard L. Kaufman, Jeffery S. Russell et al. The Lancet Oncology

Immediate Impact

8 by Nobel laureates 22 from Science/Nature 70 standout
Sub-graph 1 of 22

Citing Papers

Dendritic cell maturation in cancer
2025 Standout
Defining clinically useful biomarkers of immune checkpoint inhibitors in solid tumours
2024 Standout

Works of Shailender Bhatia being referenced

Intratumoral G100, a TLR4 Agonist, Induces Antitumor Immune Responses and Tumor Regression in Patients with Merkel Cell Carcinoma
2018
Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial
2016 Standout

Author Peers

Author Last Decade Papers Cites
Shailender Bhatia 5166 1764 2094 149 6.1k
Paul W. Harms 2131 710 799 124 4.2k
Patrick Terheyden 2739 649 793 106 3.3k
Marie‐Françoise Avril 3573 508 581 161 6.1k
Sandra P. D’Angelo 5755 625 783 188 7.5k
Axel zur Hausen 3459 710 837 138 6.4k
Roland Houben 2367 948 1111 96 3.7k
Karl D. Lewis 4782 474 584 173 7.6k
Douglas R. Fullen 3572 582 629 130 5.4k
Selma Ugurel 4756 386 464 234 8.0k
Jochen H. Lorch 2828 358 439 119 5.2k

All Works

Loading papers...

Rankless by CCL
2026